Like this article? rabble is reader-supported journalism. Chip in to keep stories like these coming.
An American pharmaceutical corporation is suing Canadian taxpayers for $500 million.
Why? Because the Canadian government rejected their patent applications, thus making more affordable versions of their medication available.
However, the Trans-Pacific Partnership will extend patents, allowing corporations to keep drug prices higher for longer.
We need to make sure Canada does not pass the TPP through Parliament.